[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9203857D0 - USE OF AN ENANTIOMERIC DIHYDROPYRIDINE - Google Patents

USE OF AN ENANTIOMERIC DIHYDROPYRIDINE

Info

Publication number
SE9203857D0
SE9203857D0 SE9203857A SE9203857A SE9203857D0 SE 9203857 D0 SE9203857 D0 SE 9203857D0 SE 9203857 A SE9203857 A SE 9203857A SE 9203857 A SE9203857 A SE 9203857A SE 9203857 D0 SE9203857 D0 SE 9203857D0
Authority
SE
Sweden
Prior art keywords
treatment
dihydropyridine
enantiomeric
alchohol
abstinence
Prior art date
Application number
SE9203857A
Other languages
Swedish (sv)
Inventor
B Samuelssoon
M Nordlander
P Thoren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9203857A priority Critical patent/SE9203857D0/en
Publication of SE9203857D0 publication Critical patent/SE9203857D0/en
Priority to AU58253/94A priority patent/AU5825394A/en
Priority to PCT/SE1993/001071 priority patent/WO1994014441A1/en
Priority to IS4109A priority patent/IS4109A/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Use of an enantiomer selected from R(+) felodipine, R(+) nitrendipine or R(+) nimodipine for the manufacture of a medicament for the treatment of stroke, chronic neurodegenerative disorders, alchohol abstinence, chronic pain conditions and other situations when cerebral ischemia may be a hazard to the patient, as well as a method for treatment and a pharmaceutical preparation for use in treatment of the same.
SE9203857A 1992-12-22 1992-12-22 USE OF AN ENANTIOMERIC DIHYDROPYRIDINE SE9203857D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9203857A SE9203857D0 (en) 1992-12-22 1992-12-22 USE OF AN ENANTIOMERIC DIHYDROPYRIDINE
AU58253/94A AU5825394A (en) 1992-12-22 1993-12-15 Use of an enantiomeric dihydropyridine
PCT/SE1993/001071 WO1994014441A1 (en) 1992-12-22 1993-12-15 Use of an enantiomeric dihydropyridine
IS4109A IS4109A (en) 1992-12-22 1993-12-20 Use of enantiomeric dihydropyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9203857A SE9203857D0 (en) 1992-12-22 1992-12-22 USE OF AN ENANTIOMERIC DIHYDROPYRIDINE

Publications (1)

Publication Number Publication Date
SE9203857D0 true SE9203857D0 (en) 1992-12-22

Family

ID=20388202

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9203857A SE9203857D0 (en) 1992-12-22 1992-12-22 USE OF AN ENANTIOMERIC DIHYDROPYRIDINE

Country Status (4)

Country Link
AU (1) AU5825394A (en)
IS (1) IS4109A (en)
SE (1) SE9203857D0 (en)
WO (1) WO1994014441A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343501A4 (en) * 2000-11-21 2004-12-15 Howard Zik Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815578C2 (en) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen New pharmaceutical use of nimodipine
DE3806277A1 (en) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg USE OF 1,4-DIHYDROPYRIDINE DERIVATIVES
EP0557290A1 (en) * 1990-08-23 1993-09-01 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
EP0555302A1 (en) * 1990-10-30 1993-08-18 The Wellcome Foundation Limited Method of treating demyelinating disease

Also Published As

Publication number Publication date
WO1994014441A1 (en) 1994-07-07
AU5825394A (en) 1994-07-19
IS4109A (en) 1994-06-23

Similar Documents

Publication Publication Date Title
ES479474A1 (en) Use of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridin-3-beta-methoxy ethylester-5-isopropylester for the preparation of cerebrally active drugs.
IT9048260A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION.
CA2149242A1 (en) Quinuclidine Derivative for Treatment of Inflammatory and Gastrointestinal Disorders
ATE84412T1 (en) A DELAYED RELEASE PHARMACEUTICAL PREPARATION OF A DIHYDROPYRIDINE AND A BETA ADRENORECEPTOR ANTAGONIST AND METHOD OF MANUFACTURE THEREOF.
IL83363A (en) Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance
HUP9700603A1 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
FR2694290B1 (en) New phenylimidazolidines which may be substituted, their preparation process, their use as medicaments and the pharmaceutical compositions containing them.
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
IT9048261A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION.
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
IT9020020A0 (en) "2-SUBSTITUTED N,N'-DITRIMETHOXYBENZOILPIPERAZINES, PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM
SE9203857D0 (en) USE OF AN ENANTIOMERIC DIHYDROPYRIDINE
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
FR2749586B1 (en) NOVEL DEVICES FOR THE TRANSDERMAL ADMINISTRATION OF TRIMEGESTONE, THEIR PREPARATION METHOD AND THEIR APPLICATION AS MEDICAMENTS
AU686976B2 (en) Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
AU7720587A (en) Substituted hexahydroarylquinolizines
AR002736A1 (en) USE OF 3-METHYL-5-ETHYL ESTER OF 2,6-DIMETHYL-4- (2,3-DICHLOROPHENYL-1,4-DIHYDROPYRIDIN-3,5-DICARBOXYLIC (FELODIPINE) TO MANUFACTURE A MEDICINE AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF BRAIN DYSFUNCTION.
ATE224716T1 (en) PHARMACEUTICAL COMPOSITIONS OF CINCHONINE DIHYDROCHLORIDE
DK0950053T3 (en) New benzoylalkyl, 1,2,3,6-tetrahydropyridine derivatives
RU2001104929A (en) METHOD FOR TREATING MULTIPLE SCLEROSIS
IL96161A0 (en) Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency
CA2080040A1 (en) Methods for preventing mycobacterial infections by administration of rifabutin
PT80521B (en) Process for the preparation of esters of the 1,4-dihydro-2,6-dimethyl-3-(alcoxicarbonyl or alcoxialcoxicarbonyl)-4-(substituted phenyl) pyridin-5-carboxylic acid of stereochemical isomers and pharmaceutically acceptable salts thereof
AU8066187A (en) Method and therapeutic compositions for the treatment of bleeding disorders